🇺🇸 CETUXIMAB in United States

7,512 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 1,164 reports (15.5%)
  2. Nausea — 929 reports (12.37%)
  3. Off Label Use — 840 reports (11.18%)
  4. Vomiting — 792 reports (10.54%)
  5. Neutropenia — 729 reports (9.7%)
  6. Dehydration — 718 reports (9.56%)
  7. Fatigue — 648 reports (8.63%)
  8. Pyrexia — 615 reports (8.19%)
  9. Malignant Neoplasm Progression — 539 reports (7.18%)
  10. Anaemia — 538 reports (7.16%)

Source database →

CETUXIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CETUXIMAB approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CETUXIMAB in United States?

Marketing authorisation holder not available in our data.